"Lavoriamo ogni giorno insieme per vincere il cancro: il CRO è un Istituto di Ricovero e Cura a Carattere Scientifico specializzato nella cura e nella ricerca sui tumori in tutte le loro fasi: prevenzione, diagnosi, trattamento e riabilitazione. L’offerta clinica del Centro di Riferimento Oncologico comprende trattamenti di oncologia medica innovativi, chirurgia generale, senologica e ginecologica, e un’avanzata radioterapia sia curativa che palliativa. Una specifica Area Giovani è dedicata agli adolescenti con tumori. La ricerca, per lo più clinica e traslazionale, copre soprattutto la genetica e la biologia dei tumori, l’epidemiologia, le neoplasie emolinfopoietiche, i tumori solidi, i tumori associati ad agenti infettivi."

During the past decade, Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C" are "Ovarian Cancer" (5 trials), "Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer" (1 trials), "Non-small Cell Lung Cancer (NSCLC)" (1 trials) and "Small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C" in a lesser frequency.

Most popular intervention types in "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C" are "Drug" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "carboplatin" (3 trials), "paclitaxel" (3 trials), "Atezolizumab" (2 trials) and "Cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C" are 5 trials for "Female" genders and 3 trials for "All" genders.

Currently, there are NaN active trials in "Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".